Characterization and side effect analysis of a newly designed nanoemulsion targeting human serum albumin for drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 98, Issue , 2012, Pages 80-84

  Divsalar, Adeleh ^a   Saboury, Ali Akbar ^b   Nabiuni, Mohammad ^a   Zare, Zohre ^b   Kefayati, Mohammad Esmaeil ^c   Seyedarabi, Arefeh ^b  

^a KHARAZMI UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Drug carrier; HSA; Intrinsic fluorescence; Nanoemulsion; Side effect

Indexed keywords

DRUG CARRIER; HSA; INTRINSIC FLUORESCENCE; NANOEMULSION; SIDE EFFECT;

BLOOD; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; NAPHTHALENE; PROTEINS; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPIC ANALYSIS; SURFACE CHEMISTRY;

FLUORESCENCE;

8 ANILINO 1 NAPHTHALENESULFONIC ACID; HUMAN SERUM ALBUMIN; SOLVENT;

ALPHA HELIX; ARTICLE; CHEMICAL INTERACTION; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIGHT SCATTERING; MORPHOLOGY; NANOEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; ULTRAVIOLET SPECTROSCOPY;

CIRCULAR DICHROISM; DRUG CARRIERS; EMULSIONS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; SERUM ALBUMIN;

EID: 84861558520     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.04.036     Document Type: Article

References (24)

1. Caterand D.C., Ho J.X. Structure and ligand binding properties of human serum albumin. Adv. Protein Chem. 1994, 45:153-203.
2. Neault J.F., Tajmir-Riahi H.A. Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure. Biochim. Biophys. Acta 1998, 1384:153-159.
3. Yang F., Bian C., Zhu L., Zhao G., Huang Z., Huang M. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin. J. Struct. Biol. 2007, 157:348-355.
4. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 2008, 132:171-183.
5. Naik N.S., Chimatadar A., Nandibewoor S.T. Interaction between a potent corticosteroid drug - dexamethasone with bovine serum albumin and human serum albumin: a fluorescence quenching and Fourier transformation infrared spectroscopy study. J. Photochem. Photobiol. B: Biol. 2010, 100:147-159.
6. Langer K., Anhorn M.G., Steinhauser L., Dreis S., Celebi D., Schrickel N., Faust S., Vogel V. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int. J. Pharm. 2008, 347:109-117.
7. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 1981, 33:17-53.
8. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
9. Solans C., Izquierdo P., Nolla J., Azemar N. Nano-emulsions. Curr. Opin. Colloid Interface Sci. 2005, 10:102-110.
10. H.A. Lieberman, M.M. Rieger, G.S. Banker, Pharmaceutical Dosage Forms: Disperse Systems, vol. 3, 2nd ed., Marcel Dekker Inc., (1998) pp. 339, 340, 343, 344.
11. Lachman L., Lieberman H.A., Kanig J.L. The Theory and Practice of Industrial Pharmacy 1987, pp. 510-511. 3rd ed.
12. Tiwari S.B., Shenoy D.B. Nanoemulsion formulations for improved oral delivery of poorly soluble drugs. 9th Annual NSTI Nanotechnology Conference and Trade Show 2006.
13. Yang J.T., Wu C.S.C., Martinez H.M. Direct determination of absolute circular dichroism data and calibration of commercial instrument. Anal. Chem. 1981, 53:778.
14. Manavalan P., Johnson C.J.R. Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra. Anal. Biochem. 1987, 167:76-85.
15. Jayasree A., Sasidharan S., Koyakutty M., Nair S., Menon M. Mannosylated chitosan-zinc sulphide nanocrystals as fluorescent bioprobes for targeted cancer imaging. Carbohydr. Polym. 2011, 85:37-43.
16. Vivian J.T., Callis P.R. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys. J. 2001, 80:2093-2109.
17. Chamani J., Asoodeh A., Homayoni-Tabrizi M., AmiriTehranizadeh Z., Baratian A., Saberi M.R., Gharanfoli M. Spectroscopic and nano-molecular modeling investigation on the binary and ternary bindings of colchicine and lomefloxacin to human serum albumin with the viewpoint of multi-drug therapy. J. Lumin. 2010, 130:2476-2486.
18. Matulis D., Baumann C.G., Bloomfield V.A., Lovrien R.E. 1-Anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopolymers 1999, 49:451-458.
19. Gabellieri E., Strambini G.B. ANS fluorescence detects widespread perturbations of protein tertiary structure in ice. Biophys. J. 2006, 90:3239-3245.
20. Matulis D., Baumann C.G., Bloomfield V.A., Lovrien R.E. 1-Anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopolymers 1999, 49:451-458.
21. Mandeville J.S., Tajmir-Riahi H.A. Complexes of dendrimers with bovine serum albumin. Biomacromolecules 2010, 11:465-472.
22. Divsalar A., Saboury A.A., Ahadi L., Zemanatiyar E., Mansouri-Torshizi H., Ajloo D., Sarma R.H. Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin. J. Biomol. Struct. Dyn. 2011, 29:283-296.
23. Mandeville J.S., Tajmir-Riahi H.A. Study of curcumin and genistein interactions with human serum albumin. J. Pharm. Biomed. Anal. 2009, 49:468-474.
24. Charbonneau D., Beauregard M., Tajmir-Riahi H.A. Structural analysis of human serum albumin complexes with cationic lipids. J. Phys. Chem. B 2009, 113:1777-1784.